Sign In
Buy AQST
$4.03
+0.100 (+2.54%)
At Close: Jun 03, 2026
5 Small Drug Stocks to Buy From a Recovering Industry
10:02am, Friday, 24'th May 2024
Innovation is expected to continue to drive the growth of the Zacks Medical-Drugs industry. HRTX, BVS, AQST, ACRV and CRDL may prove to be good additions to one's portfolio.
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
08:00am, Thursday, 09'th May 2024
WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through inno
Aquestive Therapeutics, Inc. (AQST) Q1 2024 Earnings Call Transcript
12:32pm, Wednesday, 08'th May 2024
Aquestive Therapeutics, Inc. (NASDAQ:AQST ) Q1 2024 Earnings Conference Call May 8, 2024 8:00 AM ET Company Participants Bennett Watson – ICR Westwicke Investor Relations Dan Barber – Chief Execut
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
08:01pm, Tuesday, 07'th May 2024
The headline numbers for Aquestive Therapeutics (AQST) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall
Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
06:26pm, Tuesday, 07'th May 2024
Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.11 per share a year ago.
Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
04:19pm, Tuesday, 07'th May 2024
WARREN, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innov
Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for
11:06am, Tuesday, 30'th Apr 2024
Aquestive Therapeutics (AQST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful im
Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024
01:25am, Tuesday, 09'th Apr 2024
Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024
Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note
07:21pm, Tuesday, 02'nd Apr 2024
Aquestive Therapeutics (AQST) concluded the recent trading session at $4.14, signifying a +0.24% move from its prior day's close.
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
08:00am, Monday, 25'th Mar 2024
WARREN, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful im
Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know
07:06pm, Friday, 22'nd Mar 2024
In the closing of the recent trading day, Aquestive Therapeutics (AQST) stood at $4.38, denoting no change from the preceding trading day.
Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
08:46am, Wednesday, 20'th Mar 2024
Aquestive Therapeutics (NASDAQ: AQST ) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares. Aquestive Therapeutics is selling 16,666,6
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
09:49pm, Tuesday, 19'th Mar 2024
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful im
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
04:01pm, Tuesday, 19'th Mar 2024
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (Nasdaq: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful im
